Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
Clinical trial NCT03681561 · RECRUITING
Trial details
- NCT number
- NCT03681561
- Sponsor
- Veronika Bachanova
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-13
- Primary completion
- 2026-09-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.